Saatja: Elen Ohov </o=JM/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=d1f60c90fe9d4133827e2e90805100fd-Elen Ohov>
Saaja: '
[email protected]', 'PANAGIOTAKI, Katerina', Katrin Kiisk
Teema: RE: Request to participate in active safety surveillance using cohort event monitoring for molnupiravir
Dear Madam/Sir,
Thank you for the information on the safety study of molnupiravir.
In Estonia, molnupiravir is not in use as it is undergoing the assessment in the marketing authorisation process. The expected use will probably be very low, not allowing to meet the criteria for the initiation of the study. Thus, Estonia at this stage is not in the position to participate in this project.
Best regards
Elen Ohov
Adviser | European Union Affairs and International Co-operation Department
+372 626 9241|
[email protected]
Ministry of Social Affairs
Suur-Ameerika 1 | 10122 Tallinn
626 9301 | http://www.sm.ee <http://www.sm.ee/et>
From: PANAGIOTAKI, Katerina <
[email protected]>
Sent: Tuesday, May 3, 2022 4:56 PM
To: Elen Ohov <
[email protected]>
Cc: Triin Uusberg <
[email protected]>; SM Info <
[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected]; KÖHLER, Kristina <
[email protected]>; LINDHARDT, Lisbeth Sjaelborg <
[email protected]>; PIRGARI, Dorina <
[email protected]>
Subject: Request to participate in active safety surveillance using cohort event monitoring for molnupiravir
Please see the attached correspondence sent from the World Health Organization, Regional Office for Europe. One or more attachments may be included.
Veuillez vous référer à la correspondance ci-jointe du Bureau régional de l'Europe de l'Organisation mondiale de la santé. Une ou plusieurs annexes peuvent être jointes.
Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen), Weltgesundheitsorganisation, Regionalbüro für Europa.
См. прикрепленное письмо от Европейского регионального бюро Всемирной организации здравоохранения (один или несколько прикрепленных файлов).
Katerina Panagiotaki
Access to Medicines and Health Products (AMP)
WHO Regional Office for Europe
Copenhagen, Denmark
Office: 3.3.11
Web: www.who.int <https://www.who.int/>
Follow WHO on Facebook <https://www.facebook.com/WHO/> | Twitter <https://twitter.com/WHO> | YouTube <https://www.youtube.com/user/who> | Instagram <https://www.instagram.com/who/>